无码中文字幕一Av王,91亚洲精品无码,日韩人妻有码精品专区,911亚洲精选国产青草衣衣衣

www.chinaservicesinfo.com

Videos

AstraZeneca expanding R&D pipeline in China

Updated: Oct 14, 2024 By Zhou Wenting chinadaily.com.cn Print
Share - WeChat

In an interview with China Daily, Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, said the company's presence in Shanghai is absolutely critical to achieving its bold ambition to be a pioneer in science and to create transformative new medicines for patients. She said that China has its vibrant academic collaborative network and the rich biotech ecosystem. The company will continue to grow both its pipeline and investments in Shanghai and across China, and intends to deliver at least 100 new medicines or indications in China over the next five years.

Copyright?2024 China Daily. All rights reserved.

京ICP備13028878號-6

京公網安 京公網安備 11010502032503號